Benzodiazepines: Clinical Trials

34 trials of Benzodiazepines, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 3 unknown, 3 withdrawn, 1 recruiting. 10 Phase 4, 6 Phase 2, 4 Phase 3, 3 Not applicable, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 410Completed 8, Unknown 1, Withdrawn 1
Phase 26Completed 5, Withdrawn 1
Phase 34Completed 3, Withdrawn 1
Not applicable3Completed 1, Terminated 1, Unknown 1
Phase 13Completed 3
Early Phase 11Withdrawn 1

Follow Benzodiazepines: new trials by email Literature Review of Benzodiazepines trials Research Report on Benzodiazepines

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Measuring Acute Drug Demand in Humans II
Blinded Study Medication - Condition 1, Blinded Study Medication - Condition 2, Blinded Study Medication - Condition 3 - Healthy Volunteers
Early Phase 1WithdrawnJohns Hopkins University2025-11-152025-11-12
Maternal And Infant Antipsychotic Study
Antipsychotics, Non-antipsychotic medication, No Medication - Antipsychotics, Pregnancy
RecruitingIcahn School of Medicine at Mount Sinai742023-09-292026-06-22
Side Effects of Psychiatric Medications - a Nested Case Control Cohort Historical Prospective Study
Psychiatric Drugs - Psychotic Disorders
UnknownMark Weiser, MD, Principal Investigator227772023-03-262024-03-04
Benzodiazepines in Opiate Replacement Therapy
Benzodiazepine - Substance-Related Disorders
CompletedUniversity of Stirling468992021-08-012023-03-09
Pilot RECAP Study in Healthy Volunteers
Psilocybin and Midazolam - Psychedelic Experiences, Amnesia
Phase 1CompletedUniversity of Wisconsin, Madison82021-05-212023-05-19
Benzodiazepine Discontinuation in Opioid Agonist Therapy
Distress Tolerance - Benzodiazepine Discontinuation (DT-BD), BZD discontinuation protocol - Substance Use Disorders
Phase 2CompletedBoston Medical Center42021-03-182022-02-11
Maternal and Neonatal Outcomes Following Exposure to Benzodiazepines During Pregnancy
Benzodiazepine - Pregnancy Related, Benzodiazepines Causing Adverse Effects in Therapeutic Use
CompletedSungkyunkwan University30942272020-12-012022-03-07
Effects of Experimental Sleep Disturbances on Receptor Function of Study Drug
Sleep Fragmentation, Within-Subject test of blinded study medication (stimulant, benzodiazepine, opioid, cannabinoid, over-the-counter pain medication, or placebo), Sleep Continuity Disruption - Sleep Disorder, Healthy
Phase 2CompletedJohns Hopkins University1482020-11-112025-09-24
Comparison of Postoperative Delirium in Elders Anaesthetised With Midazolam and Without Midazolam
Midazolam - Postoperative Delirium
CompletedChinese PLA General Hospital119272020-04-012022-07-18
Efficacy of Electroencephalography (EEG) Neurofeedback (NF) for the Treatment of Anxiety Disorder
SSRI or SNRI or benzodiazepines or tricyclic antidepressants or other antidepressants or antipsychotics or other sedative-hypnotics, Neurofeedback system - Anxiety Disorder, Healthy
Not applicableUnknownTianjin Anding Hospital602019-09-102021-10-19
Consequences of Doing What Should Not be Done in Primary Care
Benzodiazepines, Non-steroidal anti-inflammatory drugs, paracetamol - Overdose, Adverse Event
CompletedUniversidad Miguel Hernandez de Elche7500002018-10-142020-04-03
Maximizing Analgesia to Reduce Pain in Knee Osteoarthritis
Blinded study medication - Knee Osteoarthritis
Phase 2CompletedJohns Hopkins University582017-11-012024-12-11
Decreasing the Incidence of Delirium After Cardiac Surgery
Benzodiazepine, Fentanyl, Propofol - C.Surgical Procedure; Cardiac, Delirium
Phase 4WithdrawnUniversity of California, Los Angeles2017-08-012018-06-12
Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus
Traditional Treatment (Group T), Ketamine Infusion (Group K) - Refractory Epilepsy
Phase 2 / Phase 3WithdrawnUniversity of Alabama at Birmingham2017-05-042021-05-21
Remifentanil Effect-site Prediction by Algometry
Remifentanil 1 MG Injection [Ultiva], Midazolam 1 MG/ML Prefilled Syringe, Saline solution - Conscious Sedation Failure During Procedure
CompletedHospital Universitari Vall d'Hebron Research Institute1002017-03-012021-11-10
Gabapentin for Alcohol Withdrawal Syndrome
Gabapentin, Benzodiazepines, Divalproex Sodium - Alcohol Withdrawal Syndrome
Phase 4CompletedMayo Clinic882017-02-012022-03-24
The Assessment of POCD After TURBT Under Spinal Anesthesia
benzodiazepines, opioid, spinal anesthesia - Bladder Tumor, Postoperative Cognitive Dysfunction
Phase 4UnknownMedical University of Warsaw2002017-01-012017-01-24
Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia
Antipsychotic, Antidepressant, Benzodiazepine - Schizophrenia, Schizoaffective Disorder
CompletedNew York State Psychiatric Institute819212015-07-012024-05-01
Effects of PQ912 on the Pharmacokinetics of Midazolam and Omeprazole
PQ912, Midazolam, Omeprazole - Healthy Volunteers, Pharmacologic Action
Phase 1CompletedVivoryon Therapeutics N.V.182014-06-012015-10-21
Pregabalin for Opiate Withdrawal Syndrome
Pregabalin, Clonidine, Doxylamin - Opioid Withdrawal
Phase 4CompletedSt. Petersburg Bekhterev Research Psychoneurological Institute1002014-01-012020-04-07

Showing 20 of 34. Sign in to see all of them.

Conditions studied

Anxiety Disorders (3)  ·  Psychotic Disorders (3)  ·  Substance-Related Disorders (3)  ·  Drug Overdose (2)  ·  Seizures (2)  ·  Acute Disease (1)  ·  Aggression (1)  ·  Agnosia (1)  ·  Amnesia (1)  ·  Breast Neoplasms (1)  ·  Congenital Abnormalities (1)  ·  Delirium (1)  ·  Drug Resistant Epilepsy (1)  ·  Emergence Delirium (1)  ·  Forearm Injuries (1)

Sponsors

Johns Hopkins University (3)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  AstraZeneca (1)  ·  Boston Medical Center (1)  ·  Chinese PLA General Hospital (1)  ·  Ethicon Endo-Surgery (1)  ·  GlaxoSmithKline (1)  ·  Hospital Universitari Vall d'Hebron Research Institute (1)  ·  Hospital Universitari de Bellvitge (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Janssen Cilag N.V./S.A. (1)  ·  Mark Weiser, MD, Principal Investigator (1)  ·  Mayo Clinic (1)  ·  Medical University of Warsaw (1)  ·  Minamihanno Hospital (1)

Countries

United States (14)  ·  Spain (4)  ·  China (2)  ·  Japan (2)  ·  United Kingdom (2)  ·  Belgium (1)  ·  Israel (1)  ·  Italy (1)  ·  Poland (1)  ·  Russia (1)  ·  South Korea (1)  ·  Thailand (1)

Top investigators

Alexandra Kearson, BA (1)  ·  Alice P Chen, M.D. (1)  ·  Ana Abad-Torrent, M.D (1)  ·  Apinya Vutikullird, DO (1)  ·  Cathy D. Sherbourne, PhD (1)  ·  Christopher R Nicholas, MD,PHD (1)  ·  Claudia Campbell, PhD (1)  ·  Claudia M Campbell, Ph.D. (1)  ·  Eric C Strain, MD (1)  ·  Faris Murad, M.D. (1)  ·  Giorgio Danelli, MD (1)  ·  Greer Sullivan, MD, MSPH (1)  ·  Guido Fanelli, MD (1)  ·  Hiroto Kuwabara, MD (1)

Results publications

PMID 19212970, PMID 19829198, PMID 20146834, PMID 20483968, PMID 21168841, PMID 21367351, PMID 21464362, PMID 21762829, PMID 22152230, PMID 22304968, PMID 22404963, PMID 23184657, PMID 23225338, PMID 23290323, PMID 23332608, PMID 23370069, PMID 23377641, PMID 23407203, PMID 23580378, PMID 23608160, PMID 23729989, PMID 23750465, PMID 23801589, PMID 23886736, PMID 24338947, PMID 24619599, PMID 24660674, PMID 25272965, PMID 25562579, PMID 26563229, PMID 26994459, PMID 27775823, PMID 30232735, PMID 30837247, PMID 34009877, PMID 35235572, PMID 36302173, PMID 37469099, PMID 38485490, PMID 41481837

NIH funding

2009 (1), 2014 (1), K23DA044321 (1), R01DA042751 (1), R01HD111117 (1), U01HL150568 (1), U01MH057858 (1)